Medpace Holdings Inc (MEDP)
390.13
-9.07
(-2.27%)
USD |
NASDAQ |
May 10, 16:00
390.13
0.00 (0.00%)
After-Hours: 18:17
Medpace Holdings Cash from Financing (TTM): -122.30M for March 31, 2024
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
March 31, 2024 | -122.30M |
December 31, 2023 | -182.64M |
September 30, 2023 | -315.29M |
June 30, 2023 | -375.12M |
March 31, 2023 | -416.38M |
December 31, 2022 | -775.78M |
September 30, 2022 | -642.22M |
June 30, 2022 | -538.32M |
March 31, 2022 | -465.64M |
December 31, 2021 | -44.45M |
September 30, 2021 | -87.09M |
June 30, 2021 | -75.11M |
March 31, 2021 | -32.74M |
December 31, 2020 | -82.28M |
September 30, 2020 | -41.24M |
June 30, 2020 | -46.22M |
March 31, 2020 | -91.34M |
December 31, 2019 | -73.92M |
Date | Value |
---|---|
September 30, 2019 | -108.60M |
June 30, 2019 | -160.14M |
March 31, 2019 | -140.60M |
December 31, 2018 | -141.58M |
September 30, 2018 | -130.97M |
June 30, 2018 | -123.36M |
March 31, 2018 | -118.53M |
December 31, 2017 | -97.83M |
September 30, 2017 | -77.73M |
June 30, 2017 | -74.78M |
March 31, 2017 | -60.93M |
December 31, 2016 | -58.01M |
September 30, 2016 | -105.25M |
June 30, 2016 | -66.46M |
March 31, 2016 | -86.58M |
December 31, 2015 | -116.49M |
September 30, 2015 | -84.08M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-775.78M
Minimum
Dec 2022
-32.74M
Maximum
Mar 2021
-233.84M
Average
-115.45M
Median
Cash from Financing (TTM) Benchmarks
Charles River Laboratories International Inc | -85.52M |
Avid Bioservices Inc | 8.937M |
Iovance Biotherapeutics Inc | 462.96M |
Renovaro Inc | 8.766M |
Candel Therapeutics Inc | -0.121M |